Late Eating Tied to Poor Glucose Tolerance
By Lori Solomon HealthDay Reporter
THURSDAY, Jan. 2, 2025 -- Late consumption of calories is associated with worse glucose tolerance, according to a study published online Oct. 25 in Nutrition & Diabetes.
Diana A. Díaz-Rizzolo, Ph.D., R.D., from the Columbia University Irving Medical Center in New York City, and colleagues investigated the impact of habitual late calorie intake (≥45 percent daily calories consumed after 5 p.m.) on glucose metabolism in 26 adults with overweight or obesity and diet- or metformin-controlled prediabetes or type 2 diabetes.
The researchers found that early and late eaters did not differ in anthropometrics or daily energy intake, but late eaters consumed more carbohydrates and fats after 5 p.m. There were no differences in fasting glucose, insulin, or C-peptide between groups but late eaters exhibited higher glucose concentrations after an oral glucose tolerance test when adjusting for body weight, fat mass, energy intake, and diet composition. When participants with type 2 diabetes were excluded, glucose results remained. Differences in glucose concentrations were higher in late eaters for time 30 and 60 minutes, when adjusting for diabetes status.
"Late eating is associated with greater consumption of calories mostly from carbohydrates and fats and may lead to prolonged evening postprandial glucose excursions contributing to worse glucose tolerance," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-01-03 06:00
Read more
- Feeling Self-Conscious Is Linked to Teen Binge Drinking
- FDA Asks Biden Administration to Limit Nicotine in Tobacco Products
- Prevalence of Infant Nonsupine Sleep Position Steady From 2016 to 2022
- Singapore Is Ready for a Rapidly Aging Society, Study Says. What About the U.S.?
- 1990 to 2021 Saw Decline in Life Expectancy in the United States
- GLP-1 Zepbound Is Approved As First Drug For Sleep Apnea
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions